Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly

Ayumi Takamura, Takeshi Kawarabayashi, Tatsuki Yokoseki, Masao Shibata, Maho Morishima-Kawashima, Yuko Saito, Shigeo Murayama, Yasuo Ihara, Koji Abe, Mikio Shoji, Makoto Michikawa, Etsuro Matsubara

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Monoclonal 2C3 specific to β-amyloid (Aβ) oligomers (AβOs) enabled us to test our hypothesis that the alteration of lipoprotein-Aβ interaction in the central nervous system (CNS) initiates and/or accelerates the cascade favoring Aβ assembly. Immunoprecipitation of frontal cortex employing 2C3 unequivocally detected soluble 4-, 8-, and 12-mers in Alzheimer's disease (AD) brains. Immunoblot analysis of the entorhinal cortex employing 2C3 revealed that the accumulation of soluble 12-mers precedes the appearance of neuronal loss or cognitive impairment and is enhanced as the Braak neurofibrially tangle (NFT) stages progress. The dissociation of soluble Aβ from lipoprotein particles occurs in cerebrospinal fluid (CSF), and the presence of lipoprotein-free oligomeric 2C3 conformers (4- to 35-mers) was evident, which mimic CNS environments. Such CNS environments may strongly affect conformation of soluble Aβ peptides, resulting in the conversion of soluble Aβ42 monomers into soluble Aβ42 assembly. The findings suggest that functionally declined lipoproteins may accelerate the generation of metabolic conditions leading to higher levels of soluble Aβ42 assembly in the CNS.

Original languageEnglish
Pages (from-to)815-821
Number of pages7
JournalJournal of Neuroscience Research
Volume89
Issue number6
DOIs
Publication statusPublished - Jun 2011

Fingerprint

Amyloid
Lipoproteins
Cerebrospinal Fluid
Alzheimer Disease
Central Nervous System
Entorhinal Cortex
Frontal Lobe
Immunoprecipitation
Peptides
Brain

Keywords

  • Alzheimer's disease
  • Lipoprotein
  • Monomer
  • Oligomer

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Takamura, A., Kawarabayashi, T., Yokoseki, T., Shibata, M., Morishima-Kawashima, M., Saito, Y., ... Matsubara, E. (2011). Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly. Journal of Neuroscience Research, 89(6), 815-821. https://doi.org/10.1002/jnr.22615

Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly. / Takamura, Ayumi; Kawarabayashi, Takeshi; Yokoseki, Tatsuki; Shibata, Masao; Morishima-Kawashima, Maho; Saito, Yuko; Murayama, Shigeo; Ihara, Yasuo; Abe, Koji; Shoji, Mikio; Michikawa, Makoto; Matsubara, Etsuro.

In: Journal of Neuroscience Research, Vol. 89, No. 6, 06.2011, p. 815-821.

Research output: Contribution to journalArticle

Takamura, A, Kawarabayashi, T, Yokoseki, T, Shibata, M, Morishima-Kawashima, M, Saito, Y, Murayama, S, Ihara, Y, Abe, K, Shoji, M, Michikawa, M & Matsubara, E 2011, 'Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly', Journal of Neuroscience Research, vol. 89, no. 6, pp. 815-821. https://doi.org/10.1002/jnr.22615
Takamura, Ayumi ; Kawarabayashi, Takeshi ; Yokoseki, Tatsuki ; Shibata, Masao ; Morishima-Kawashima, Maho ; Saito, Yuko ; Murayama, Shigeo ; Ihara, Yasuo ; Abe, Koji ; Shoji, Mikio ; Michikawa, Makoto ; Matsubara, Etsuro. / Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly. In: Journal of Neuroscience Research. 2011 ; Vol. 89, No. 6. pp. 815-821.
@article{2d4d4586005643598f827c73a2a24889,
title = "Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly",
abstract = "Monoclonal 2C3 specific to β-amyloid (Aβ) oligomers (AβOs) enabled us to test our hypothesis that the alteration of lipoprotein-Aβ interaction in the central nervous system (CNS) initiates and/or accelerates the cascade favoring Aβ assembly. Immunoprecipitation of frontal cortex employing 2C3 unequivocally detected soluble 4-, 8-, and 12-mers in Alzheimer's disease (AD) brains. Immunoblot analysis of the entorhinal cortex employing 2C3 revealed that the accumulation of soluble 12-mers precedes the appearance of neuronal loss or cognitive impairment and is enhanced as the Braak neurofibrially tangle (NFT) stages progress. The dissociation of soluble Aβ from lipoprotein particles occurs in cerebrospinal fluid (CSF), and the presence of lipoprotein-free oligomeric 2C3 conformers (4- to 35-mers) was evident, which mimic CNS environments. Such CNS environments may strongly affect conformation of soluble Aβ peptides, resulting in the conversion of soluble Aβ42 monomers into soluble Aβ42 assembly. The findings suggest that functionally declined lipoproteins may accelerate the generation of metabolic conditions leading to higher levels of soluble Aβ42 assembly in the CNS.",
keywords = "Aβ, Alzheimer's disease, Lipoprotein, Monomer, Oligomer",
author = "Ayumi Takamura and Takeshi Kawarabayashi and Tatsuki Yokoseki and Masao Shibata and Maho Morishima-Kawashima and Yuko Saito and Shigeo Murayama and Yasuo Ihara and Koji Abe and Mikio Shoji and Makoto Michikawa and Etsuro Matsubara",
year = "2011",
month = "6",
doi = "10.1002/jnr.22615",
language = "English",
volume = "89",
pages = "815--821",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly

AU - Takamura, Ayumi

AU - Kawarabayashi, Takeshi

AU - Yokoseki, Tatsuki

AU - Shibata, Masao

AU - Morishima-Kawashima, Maho

AU - Saito, Yuko

AU - Murayama, Shigeo

AU - Ihara, Yasuo

AU - Abe, Koji

AU - Shoji, Mikio

AU - Michikawa, Makoto

AU - Matsubara, Etsuro

PY - 2011/6

Y1 - 2011/6

N2 - Monoclonal 2C3 specific to β-amyloid (Aβ) oligomers (AβOs) enabled us to test our hypothesis that the alteration of lipoprotein-Aβ interaction in the central nervous system (CNS) initiates and/or accelerates the cascade favoring Aβ assembly. Immunoprecipitation of frontal cortex employing 2C3 unequivocally detected soluble 4-, 8-, and 12-mers in Alzheimer's disease (AD) brains. Immunoblot analysis of the entorhinal cortex employing 2C3 revealed that the accumulation of soluble 12-mers precedes the appearance of neuronal loss or cognitive impairment and is enhanced as the Braak neurofibrially tangle (NFT) stages progress. The dissociation of soluble Aβ from lipoprotein particles occurs in cerebrospinal fluid (CSF), and the presence of lipoprotein-free oligomeric 2C3 conformers (4- to 35-mers) was evident, which mimic CNS environments. Such CNS environments may strongly affect conformation of soluble Aβ peptides, resulting in the conversion of soluble Aβ42 monomers into soluble Aβ42 assembly. The findings suggest that functionally declined lipoproteins may accelerate the generation of metabolic conditions leading to higher levels of soluble Aβ42 assembly in the CNS.

AB - Monoclonal 2C3 specific to β-amyloid (Aβ) oligomers (AβOs) enabled us to test our hypothesis that the alteration of lipoprotein-Aβ interaction in the central nervous system (CNS) initiates and/or accelerates the cascade favoring Aβ assembly. Immunoprecipitation of frontal cortex employing 2C3 unequivocally detected soluble 4-, 8-, and 12-mers in Alzheimer's disease (AD) brains. Immunoblot analysis of the entorhinal cortex employing 2C3 revealed that the accumulation of soluble 12-mers precedes the appearance of neuronal loss or cognitive impairment and is enhanced as the Braak neurofibrially tangle (NFT) stages progress. The dissociation of soluble Aβ from lipoprotein particles occurs in cerebrospinal fluid (CSF), and the presence of lipoprotein-free oligomeric 2C3 conformers (4- to 35-mers) was evident, which mimic CNS environments. Such CNS environments may strongly affect conformation of soluble Aβ peptides, resulting in the conversion of soluble Aβ42 monomers into soluble Aβ42 assembly. The findings suggest that functionally declined lipoproteins may accelerate the generation of metabolic conditions leading to higher levels of soluble Aβ42 assembly in the CNS.

KW - Aβ

KW - Alzheimer's disease

KW - Lipoprotein

KW - Monomer

KW - Oligomer

UR - http://www.scopus.com/inward/record.url?scp=79954625121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954625121&partnerID=8YFLogxK

U2 - 10.1002/jnr.22615

DO - 10.1002/jnr.22615

M3 - Article

C2 - 21394760

AN - SCOPUS:79954625121

VL - 89

SP - 815

EP - 821

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 6

ER -